Police in St Petersburg are said to be investigating former employees of the Russian business of Swiss drugmaker Roche (ROG: SIX), in connection with theft allegations relating to MabThera (rituximab).
Reports indicate that the unnamed Roche employees are been investigated for stealing and reselling supplies of MabThera on the black market for up to a million dollars.
The allegations relate to suspicious prescriptions for over 1,300 packets of the therapy from doctors at the St Petersburg City Clinical Oncology Dispensary.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze